Perspective Therapeutics (AAJ0) Income Statement
Perspective Therapeutics Income Statement
Last quarter (Q2 2026), Perspective Therapeutics's total revenue was $81.00K, a decrease of 72.07% from the same quarter last year. In Q2, Perspective Therapeutics's net income was $-26.79M. See Perspective Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 1.45M | $ 1.43M | $ 5.42M | $ 10.79M | |
| $ 0.00 | $ -852.00K | $ 1.43M | $ 2.37M | $ 4.62M | |
| $ 113.56M | $ 65.94M | $ 42.38M | $ 11.47M | $ 12.01M | |
| Depreciation and Amortization | $ 3.25M | $ 2.31M | $ 986.00K | $ 324.00K | $ 248.00K |
| $ -100.80M | $ -64.49M | $ -39.95M | $ -8.47M | $ -7.14M | |
| $ -113.56M | $ -66.80M | $ -40.94M | $ -9.10M | $ -7.39M | |
| $ 9.14M | $ -13.63M | $ 835.00K | $ 618.00K | $ 119.00K | |
| $ -104.43M | $ -80.43M | $ -40.11M | $ -8.48M | $ -7.27M | |
| $ -103.12M | $ -79.28M | $ -46.51M | $ -10.76M | $ -7.27M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.40 | $ -1.23 | $ -0.85 | $ -0.60 | $ -0.50 |
| Diluted EPS | $ -1.40 | $ -1.23 | $ -0.85 | $ -0.60 | $ -0.50 |
| Weighted Average Shares Outstanding | 73.81M | 64.42M | 54.91M | 18.02M | 14.20M |
| Weighted Average Shares Outstanding (Diluted) | 73.81M | 64.42M | 54.91M | 14.21M | 14.20M |
Currency in USD
